Vimarsana
Biggest News Aggregation in the World

Page 40 - Real World Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Real World Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Real World Data Today - Breaking & Trending Today

Guardian Research Network® to Speak at PMWC 2022 About Advances in Applying Real World Data to Clinical Research - Vimarsana News

Guardian Research Network® to Speak at PMWC 2022 About Advances in Applying Real World Data to Clinical Research

/PRNewswire/ -- The Guardian Research Network Inc (GRN), a non-profit nationwide healthcare research consortium, is excited to announce that Adam Chasse,...

InsightAce Analytic Pvt. Ltd.: AI in Biopharmaceutical Development Market worth $16.4 Billion by 2030 - Vimarsana News

InsightAce Analytic Pvt. Ltd.: AI in Biopharmaceutical Development Market worth $16.4 Billion by 2030

JERSEY CITY, N.J., May 26, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global AI in Biopharmaceutical Development Market (Type

AI in Biopharmaceutical Development Market worth $16.4 Billion by 2030 - Exclusive Report by InsightAce Analytic - Vimarsana News

AI in Biopharmaceutical Development Market worth $16.4 Billion by 2030 - Exclusive Report by InsightAce Analytic

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global AI in Biopharmaceutical Development Market...

New Data Presented at DDW 2022 Shows Nearly Two-Fold Risk of Loss of Remission in Ulcerative Colitis Patients who had Histologic Inflammation on Baseline Biopsy - Vimarsana News

New Data Presented at DDW 2022 Shows Nearly Two-Fold Risk of Loss of Remission in Ulcerative Colitis Patients who had Histologic Inflammation on Baseline Biopsy

/PRNewswire/ -- New data shows that more than a third (36.6%) of ulcerative colitis (UC) patients who have previously responded to advanced therapies...

New Data Presented at DDW 2022 Shows Nearly Two-Fold Risk of Loss of Remission in Ulcerative Colitis Patients who had Histologic Inflammation on Baseline Biopsy - Vimarsana News

New Data Presented at DDW 2022 Shows Nearly Two-Fold Risk of Loss of Remission in Ulcerative Colitis Patients who had Histologic Inflammation on Baseline Biopsy

/PRNewswire/ -- New data shows that more than a third (36.6%) of ulcerative colitis (UC) patients who have previously responded to advanced therapies...